Clinical Trial

Open Label Trial of Deceased Donor Livers Transplanted After DHOPE With eXVIVO LIVER Perfusion

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to confirm the safety and effectiveness of dual hypothermic oxygenated perfusion (DHOPE) using the Liver Assist to preserve deceased donor livers for transplantation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-31.
Trial Details
NCT Number NCT06916325
Lead Sponsor XVIVO Perfusion
Conditions Liver Transplant Surgery, Liver Transplantation
Enrollment 215 participants
Start Date 2027-01
Primary Completion 2028-10 (estimated)
Study Completion 2033-04 (estimated)
Updated on ClinicalTrials.gov 2026-04-21